[Sodium transport inhibitor in hypertensives].
The content of sodium transport inhibitor (STI) in the blood and urine was studied in 106 patients with hypertensive disease (HD) in comparison with the clinical course of the disease. STI secretion influenced actively the main parameters of the water-salt homeostasis and hemodynamics in patients with juvenile hypertension and in patients with benign course of HD. In severe progressing course of HD, STI disappears from the blood and urine that may further progression of the disease.
Shul'ga
Iu D
IuD
Berezniakov
I G
IG
D000293:Adolescent; D000328:Adult; D001693:Biological Transport, Active / Q000502:physiology; D005260:Female; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000032:analysis*; D012964:Sodium / Q000037:antagonists & inhibitors* / Q000097:blood / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
D010455:Peptides; C029311:serum sodium transport inhibitor; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase
Ingibitor transporta natriia u bol'nykh gipetonicheskoĭ bolezn'iu.